Digital Self-Monitoring Effective for Weight Loss, Healthy Lifestyle
Finding significantly associated with tailored advice among adults with obesity, overweight
Glycemic Control Has Not Been Impacted by Pandemic
Despite drop in diabetes-related outpatient visits and testing, no negative association found with glycemic control
Patient Engagement May Not Drive Return to In-Person Visits
Findings seen among patients receiving letter during reopening following cancellation of in-person care during COVID-19
Glucose-Lowering Therapy Delayed for Newly Diagnosed T2DM Patients
Factors in therapeutic inertia examined in adults newly diagnosed with T2DM receiving primary care in the U.K.
Gestational Diabetes May Increase Risk for Fetal Hypoxia
Hypoxia-related ZigZag pattern, late decelerations of FHR on intrapartal CTG and increased risk of fetal asphyxia seen in GDM pregnancies
Biden Administration Pushes Forward With Law on Surprise Medical Bills
Proposed provisions would more clearly outline charges to be expected during medical emergencies, offer protections to consumers
Medication Type for T2DM May Affect Severe COVID-19 Outcomes
Premorbid GLP1-RA use, SGLT2i use associated with lower 60-day mortality compared to premorbid DPP4i use
ADA: Peds Hospitalization Rates for New-Onset T2DM Up During Pandemic
Hospitalization rate for new onset diabetes up from 0.27 percent in 2019 to 0.62 percent in 2020; mean admission HbA1c, glucose also higher
Drop Seen in Physician Work Hours During COVID-19 Pandemic
Full-time status significantly declined among female physicians with preschool-aged children
ADA: Tirzepatide Noninferior, Superior to Semaglutide for T2DM
Greater reduction in glycated hemoglobin levels and improved weight loss seen with tirzepatide in type 2 diabetes
